Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) reported Q2 EPS of ($1.07), $0.34 worse than the analyst estimate of ($0.73).

For earnings history and earnings-related data on Amylyx Pharmaceuticals, Inc. (AMLX) click here.